References: Salas RN, Maibach E, Pencheon D, Watts N, Frumkin H. A pathway to net zero emissions for healthcare. BMJ. 2020;371:m3785. doi:10.1136/bmj.m3785.
Ahmad A, Ikram A, Rehan MF, Ahmad A. Going green: impact of green supply chain management practices on sustainability performance. Front Psychol. 2022;13:973676. doi:10.3389/fpsyg.2022.973676.
Malik A, Lenzen M, McAlister S, McGain F. The carbon footprint of Australian health care. Lancet Planet Health. 2018;2(1):e27-e35. doi:10.1016/S2542-5196(17)30180-8.
Singh R, Kumar S. Green Technologies and Environmental Sustainability. Springer Cham; 2017.
Purohit A, Smith J, Hibble A. Does telemedicine reduce the carbon footprint of healthcare? A systematic review. Future Healthc J. 2021;8(1):e85-e91. doi:10.7861/fhj.2020-0080.
Pfaar O, Klimek L, Jutel M, et al. COVID-19 pandemic: practical considerations on the organization of an allergy clinic-an EAACI/ARIA position paper. Allergy. 2021;76(3):648-676. doi:10.1111/all.14453.
Ramsey A, Wu AC, Bender BG, Portnoy J. Teleallergy: where have we been and where are we going? J Allergy Clin Immunol Pract. 2023;11(1):126-131. doi:10.1016/j.jaip.2022.08.032.
Whitmee S, Haines A, Beyrer C, et al. Safeguarding human health in the Anthropocene epoch: report of the Rockefeller Foundation-Lancet Commission on planetary health. Lancet. 2015;386(10007):1973-2028. doi:10.1016/S0140-6736(15)60901-1.
Halonen JI, Erhola M, Furman E, et al. The Helsinki declaration 2020: Europe that protects. Lancet Planet Health. 2020;4(11):e503-e505. doi:10.1016/S2542-5196(20)30242-4.
Halonen JI, Erhola M, Furman E, et al. A call for urgent action to safeguard our planet and our health in line with the Helsinki declaration. Environ Res. 2021;193:110600. doi:10.1016/j.envres.2020.110600.
Haahtela T, Valovirta E, Saarinen K, et al. The Finnish Allergy Program 2008-2018: society-wide proactive program for change of management to mitigate allergy burden. J Allergy Clin Immunol. 2021;148(2):319-326.e4. doi:10.1016/j.jaci.2021.03.037.
Sousa-Pinto B, Anto A, Berger M, et al. Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities. Clin Transl Allergy. 2022;12(11):e12208. doi:10.1002/clt2.12208.
Interoperable Europe Act Proposal. 2022. https://commission.europa.eu/publications/interoperable-europe-act-proposal_en.
Bedard A, Sofiev M, Arnavielhe S, et al. Interactions between air pollution and pollen season for rhinitis using mobile technology: a MASK-POLLAR study. J Allergy Clin Immunol Pract. 2020;8(3):1063-1073.e4. doi:10.1016/j.jaip.2019.11.022.
Bousquet J, Anto JM, Annesi-Maesano I, et al. POLLAR: impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy. 2018;8:36. doi:10.1186/s13601-018-0221-z.
Bousquet J, Anto JM, Haahtela T, et al. Digital transformation of health and care to sustain planetary health: the MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing. Clin Transl Allergy. 2020;10:24. doi:10.1186/s13601-020-00321-2.
Janson C, Maslova E, Wilkinson A, et al. The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme. Eur Respir J. 2022;60(2):2102760. doi:10.1183/13993003.02760-2021.
Pleasants RA, Chan AH, Mosnaim G, et al. Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease. Respir Med. 2022;205:107038. doi:10.1016/j.rmed.2022.107038.
Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372-1392. doi:10.1111/all.12686.
Sofiev M, Palamarchuk Y, Bedard A, et al. A demonstration project of Global Alliance against Chronic Respiratory Diseases: prediction of interactions between air pollution and allergen exposure-the Mobile Airways Sentinel networK-impact of air POLLution on Asthma and Rhinitis approach. Chin Med J. 2020;133(13):1561-1567. doi:10.1097/CM9.0000000000000916.
Hämäläinen R-M, Halonen JI, Haveri H, et al. Nature step to health 2022-2032: interorganizational collaboration to prevent human disease, nature loss, and climate crisis. J Clim Chang Health. 2022;10:100194.
Bousquet J, Agache I, Aliberti MR, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy. 2018;73(1):77-92. doi:10.1111/all.13218.
Bousquet J, Bewick M, Arnavielhe S, et al. Work productivity in rhinitis using cell phones: the MASK pilot study. Allergy. 2017;72(10):1475-1484. doi:10.1111/all.13177.
Bousquet J, Bedbrook A, Czarlewski W, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9:16. doi:10.1186/s13601-019-0252-0.
Menditto E, Costa E, Midao L, et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK study. Clin Exp Allergy. 2019;49(4):442-460. doi:10.1111/cea.13333.
Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy. 2018;73(9):1763-1774. doi:10.1111/all.13406.
Bousquet J, Sousa-Pinto B, Anto J, et al. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app. Pulmonology. 2022;29:292-305.
Sousa-Pinto B, Sa-Sousa A, Amaral R, et al. Assessment of the control of allergic rhinitis and asthma test (CARAT) using MASK-air. J Allergy Clin Immunol Pract. 2022;10(1):343-345.e2. doi:10.1016/j.jaip.2021.09.012.
Sousa-Pinto B, Sa-Sousa A, Vieira RJ, et al. Behavioural patterns in allergic rhinitis medication in Europe: a study using MASK-air® real-world data. Allergy. 2022;77(9):2699-2711. doi:10.1111/all.15275.
Sousa-Pinto B, Schunemann HJ, Sa-Sousa A, et al. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference. Allergy. 2022;77(10):3002-3014. doi:10.1111/all.15371.
Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144(1):135-143.e6. doi:10.1016/j.jaci.2019.01.053.
Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019;74(11):2087-2102. doi:10.1111/all.13805.
Bousquet JJ, Schunemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44. doi:10.1186/s13601-019-0279-2.
Bousquet J, Toumi M, Sousa-Pinto B, et al. The allergic rhinitis and its impact on asthma (ARIA) approach of value-added medicines: as-needed treatment in allergic rhinitis. J Allergy Clin Immunol Pract. 2022;10(11):2878-2888. doi:10.1016/j.jaip.2022.07.020.
Bousquet J, Arnavielhe S, Bedbrook A, et al. The allergic rhinitis and its impact on asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: the MASK study. Allergy. 2018;73(2):505-510. doi:10.1111/all.13307.
Reijula J, Latvala J, Makela M, Siitonen S, Saario M, Haahtela T. Long-term trends of asthma, allergic rhinitis and atopic eczema in young Finnish men: a retrospective analysis, 1926-2017. Eur Respir J. 2020;56(6):1902144. doi:10.1183/13993003.02144-2019.
Processing Request
No Comments.